中文 | English
Return
Total: 596 , 1/60
Show Home Prev Next End page: GO
Author:(Xiaoyan XU)

1.Perspectives on the Status Quo of the Research on Clinical Pharmacokinetics of Traditional Chinese Medicine

Xiaoyan XU

China Pharmacy 2005;0(24):-

2.Treatment of burn residual wounds with recombinant bovine basic fibroblast growth factor

Xiaoyan XU

Chinese Journal of Rehabilitation Theory and Practice 2002;8(10):621-621

3.Practice and Research on Subject-oriented and Specialization Information Service

Xiaoyan ZHU ; Rong XU

International Journal of Traditional Chinese Medicine 2008;30(5):332-333

4.Ephedrine and dopamine's hypotension-preventative effect for CSEA in cesarean delivery-A single-blind controlled study

Xiaoyan TANG ; Jinmei XU

Chinese Journal of Primary Medicine and Pharmacy 2015;(8):1193-1195

5.Transfecting human elafin gene recombinant plasmid protects NCI-H292 cell line

Xiaoyan XU ; Xiangdong ZHOU

Basic & Clinical Medicine 2006;0(03):-

6.Over-expressed miR-449a inhibitsproliferation and induces apoptosis of SH-SY5Y cells in vitro

Xiaoyan XU ; Xiaoshan LI

Basic & Clinical Medicine 2017;37(8):1117-1121

7.Notice for Western Medicine Physicians in Clinical Use of Chinese Patent Drugs

Xiaoyan XU ; Jun ZHOU

China Pharmacy 2007;0(36):-

8.Clinical Study on Acupuncture and Miuci Therapy Combined with Qinggan Tongqiao Decoction for Treating Sudden Sensor-neural Hearing Loss

Xiaoyan FU ; Changqing XU

Chinese Journal of Information on Traditional Chinese Medicine 2017;24(5):31-34

9.Protective role of lipoxins in digestive diseases

Hongrong XU ; Xiaoyan ZHOU

Chinese Journal of Pathophysiology 2014;(7):1223-1227

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 596 , 1/60 Show Home Prev Next End page: GO